Advertisement

Topics

Denali and AbCellera to collaborate on treating neurodegenerative disease

19:00 EDT 12 Jun 2018 | Pharmaceutical Technology

US-based biopharmaceutical company Denali Therapeutics has formed an alliance with Canadian therapeutic discovery firm AbCellera Biologics to identify new antibodies...
Read More...

The post Denali and AbCellera to collaborate on treating neurodegenerative disease appeared first on Pharmaceutical Technology.

Original Article: Denali and AbCellera to collaborate on treating neurodegenerative disease

NEXT ARTICLE

More From BioPortfolio on "Denali and AbCellera to collaborate on treating neurodegenerative disease"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...

Biotherapeutics
The field encompassing therapeutic materials produced using biological means, including recombinant DNA technology. Biotherapeutics, also known as biotech drugs or biologics, are therapies derived from living organisms. By harnessing these living cells...